| Written by Mercola |
| Tuesday, 30 November 2010 00:00 |
|
Mercola
In April, the government of India called a halt to trials of the Human Papilloma Virus (HPV) vaccine. This came about because of a civil society-led investigation which highlighted serious ethical violations in at least one trial. In India, civil society groups have long been voicing their concerns regarding the safety and efficacy of the two HPV vaccines, along with the unethical promotion of the vaccines and the need to investigate reported deaths and adverse events post vaccination. According to Economic and Political Weekly, the investigation the led to the ban highlights how: "... the promotional practices of drug companies, pressure from powerful international organizations, and the co-option of, and uncritical endorsement by, India’s medical associations are influencing the country’s public health priorities." Sources:Original Article |